Clinical trials in osteoarthritis - what should be the controls?

被引：0
|
作者：
Maurer, BT [1 ]
Oatis, CA [1 ]
机构：
[1] Wyeth Ayerst Res C1, Philadelphia, PA 19101 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 1999年 / 5卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 115
页数：3
相关论文
共 50 条
  • [1] What should be considered in clinical trials?
    Ehlers, Alexander P. F.
    Bartholomae, Julian
    Becker, Carolin
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2023, 161 (04): : 359 - 365
  • [2] Clinical trials: what are we afraid of, what should we do?
    Darsaut, Tim E.
    Raymond, Jean
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2016, 8 (E1) : E14 - E16
  • [3] Requirements for clinical trials in osteoporosis and osteoarthritis: What is new in 2006?
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S119 - S119
  • [4] What should be the core outcomes in chronic pain clinical trials?
    Turk, DC
    Dworkin, RH
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) : 151 - 154
  • [5] CLINICAL-TRIALS OF RADIOSENSITIZERS - WHAT SHOULD WE EXPECT
    BROWN, JM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (03): : 425 - 429
  • [6] Composite outcomes in clinical trials: what are they and when should they be used?
    Heddle, Nancy M.
    Cook, Richard J.
    TRANSFUSION, 2011, 51 (01) : 11 - 13
  • [7] What Should Be Done About Bias and Misconduct in Clinical Trials?
    Fairman, Kathleen A.
    Curtiss, Frederic R.
    JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (02): : 154 - 160
  • [8] Major clinical trials of hypertension - What should be done next?
    Alderman, MH
    Arnett, DK
    Bakris, GL
    Black, HR
    Boerwinkle, E
    Califf, RM
    Cushman, WC
    Cutler, J
    Davis, BR
    Devereux, RB
    Ferdinand, K
    Fleg, JL
    Fournier, A
    Furberg, CD
    Giles, TD
    Gottdiener, JS
    Grimm, RH
    Hyman, DJ
    Jamerson, KA
    Kostis, JB
    Krauss, RM
    Leenen, FHH
    Levey, AS
    Levy, D
    MacMahon, S
    Oparil, S
    Probstfield, JL
    Psaty, BM
    Roccella, E
    Salive, M
    Schwartz, WB
    Svetkey, L
    Throckmorton, D
    Turner, ST
    Velletri, P
    Wright, J
    HYPERTENSION, 2005, 46 (01) : 1 - 6
  • [9] What should be the ideal design of phase I clinical trials?
    Lau, Derick
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S76 - S76
  • [10] What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?
    Grill, Joshua D.
    Sperling, Reisa A.
    Raman, Rema
    JAMA NEUROLOGY, 2022, 79 (11) : 1097 - 1098
12345